193 related articles for article (PubMed ID: 31588646)
1. Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions.
van Houdt PJ; Ghobadi G; Schoots IG; Heijmink SWTPJ; de Jong J; van der Poel HG; Pos FJ; Rylander S; Bentzen L; Haustermans K; van der Heide UA
J Magn Reson Imaging; 2020 Apr; 51(4):1235-1246. PubMed ID: 31588646
[TBL] [Abstract][Full Text] [Related]
2. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
[TBL] [Abstract][Full Text] [Related]
3. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
5. The visibility of prostate cancer concerning underlying histopathological variances: A single-center multiparametric magnetic resonance imaging study.
Arslan A; Alis D; Tuna MB; Sağlıcan Y; Kural AR; Karaarslan E
Eur J Radiol; 2021 Aug; 141():109791. PubMed ID: 34062471
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.
Cai Q; Costa DN; Metter CK; Goldberg K; Roehrborn CG; Cadeddu J; Pedrosa I; Meng X; Mostardeiro TR; Shah RB
Urol Oncol; 2022 Oct; 40(10):452.e1-452.e8. PubMed ID: 36008255
[TBL] [Abstract][Full Text] [Related]
7. Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external-beam radiation therapy.
Dinis Fernandes C; van Houdt PJ; Heijmink SWTPJ; Walraven I; Keesman R; Smolic M; Ghobadi G; van der Poel HG; Schoots IG; Pos FJ; van der Heide UA
J Magn Reson Imaging; 2019 Jul; 50(1):269-278. PubMed ID: 30585368
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard.
Gibbons M; Simko JP; Carroll PR; Noworolski SM
Magn Reson Imaging; 2023 Jun; 99():48-57. PubMed ID: 36641104
[TBL] [Abstract][Full Text] [Related]
9. Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.
Broeke NC; Peterson J; Lee J; Martin PR; Farag A; Gomez JA; Moussa M; Gaed M; Chin J; Pautler SE; Ward A; Bauman G; Bartha R; Scholl TJ
J Magn Reson Imaging; 2019 May; 49(5):1409-1419. PubMed ID: 30430700
[TBL] [Abstract][Full Text] [Related]
10. All over the map: An interobserver agreement study of tumor location based on the PI-RADSv2 sector map.
Greer MD; Shih JH; Barrett T; Bednarova S; Kabakus I; Law YM; Shebel H; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2018 Aug; 48(2):482-490. PubMed ID: 29341356
[TBL] [Abstract][Full Text] [Related]
11. 3T multiparametric MR imaging, PIRADSv2-based detection of index prostate cancer lesions in the transition zone and the peripheral zone using whole mount histopathology as reference standard.
Asvadi NH; Afshari Mirak S; Mohammadian Bajgiran A; Khoshnoodi P; Wibulpolprasert P; Margolis D; Sisk A; Reiter RE; Raman SS
Abdom Radiol (NY); 2018 Nov; 43(11):3117-3124. PubMed ID: 29725743
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
13. The cribriform morphology impairs Gleason 7 prostate cancer lesion detection on multiparametric magnetic resonance imaging.
Kazan O; Gunduz N; Kir G; Iplikci A; Dogan MB; Cecikoglu GE; Culpan M; Yildirim A
Prostate; 2023 Mar; 83(4):331-339. PubMed ID: 36477738
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of
Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
[TBL] [Abstract][Full Text] [Related]
15. Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis.
Norris JM; Carmona Echeverria LM; Simpson BS; Ball R; Freeman A; Kelly D; Kirkham A; Whitaker HC; Emberton M
BMJ Open; 2020 Oct; 10(10):e039735. PubMed ID: 33093035
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
17. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
[TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.
Gaur S; Harmon S; Mehralivand S; Bednarova S; Calio BP; Sugano D; Sidana A; Merino MJ; Pinto PA; Wood BJ; Shih JH; Choyke PL; Turkbey B
J Magn Reson Imaging; 2018 Nov; 48(5):1326-1335. PubMed ID: 29603833
[TBL] [Abstract][Full Text] [Related]
19. Central zone lesions on magnetic resonance imaging: Should we be concerned?
Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
[TBL] [Abstract][Full Text] [Related]
20. What to expect from a non-suspicious prostate MRI? A review.
Fiard G; Norris JM; Nguyen TA; Stavrinides V; Olivier J; Emberton M; Moore CM
Prog Urol; 2020 Dec; 30(16):986-999. PubMed ID: 33008718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
